-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $71

Benzinga·04/28/2026 18:02:28
Listen to the news
Jefferies analyst Roger Song maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy and raises the price target from $58 to $71.